This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
Â
View Excel Document
Financial Statements
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements of Operations (Unaudited)
Condensed Consolidated Statements of Comprehensive (Loss)/Income (Unaudited)
Condensed Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
Organization and Business Overview
Basis of Presentation, Liquidity and Summary of Significant Accounting Policies
Asterias Merger
Accounting for Common Stock of OncoCyte, at Fair Value
Sale of Significant Ownership Interest in AgeX to Juvenescence Limited
Property and Equipment, Net
Goodwill and Intangible Assets, Net
Accounts Payable and Accrued Liabilities
Fair Value Measurements
Related Party Transaction
Shareholders’ Equity
Stock-Based Awards
Income Taxes
Supplemental Cash Flow Information
Commitments and Contingencies
Subsequent Events
Accounting Policies
Basis of Presentation, Liquidity and Summary of Significant Accounting Policies (Policies)
Notes Tables
Basis of Presentation, Liquidity and Summary of Significant Accounting Policies (Tables)
Asterias Merger (Tables)
Property and Equipment, Net (Tables)
Goodwill and Intangible Assets, Net (Tables)
Accounts Payable and Accrued Liabilities (Tables)
Fair Value Measurements (Tables)
Shareholders’ Equity (Tables)
Stock-Based Awards (Tables)
Supplemental Cash Flow Information (Tables)
Commitments and Contingencies (Tables)
Notes Details
Organization and Business Overview (Details Narrative)
Schedule of Lineage's Ownership of Outstanding Shares of its Subsidiaries (Details)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)
Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash (Details)
Schedule of Merger Consideration Transferred (Details)
Schedule of Identifiable Tangible and Intangible Assets Acquired and Liabilities Assumed (Details)
Schedule of Valuation of Identifiable Intangible Assets and Their Estimated Useful Lives (Details)
Asterias Merger (Details Narrative)
Accounting for Common Stock of OncoCyte, at Fair Value (Details Narrative)
Schedule of Property and Equipment, Net (Details)
Property and Equipment, Net (Details Narrative)
Schedule of Goodwill and Intangible Assets, Net (Details)
Goodwill and Intangible Assets, Net (Details Narrative)
Schedule of Accounts Payable and Accrued Liabilities (Details)
Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details)
Fair Value Measurements (Details Narrative)
Related Party Transaction (Details Narrative)
Schedule of Shareholders' Equity (Details)
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity and Other Stock Options (Details)
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity (Details)
Schedule of Weighted Average Assumptions to Calculate Fair Value of Stock Options (Details)
Schedule of Stock Based Compensation Expense (Details)
Stock-Based Awards (Details Narrative)
Schedule of Supplemental Cash Flow Information (Details)
Schedule of Supplemental Cash Flow Information Related to Leases (Details)
Schedule of Supplemental Balance Sheet Information Related to Leases (Details)
Schedule of Future Minimum Lease Commitments (Details)
Commitments and Contingencies (Details Narrative)
Subsequent Events (Details Narrative)
Uncategorized
Uncategorized Items - form10-q_htm.xml
All Reports